Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
Nuclear Medicine
AV45 (R+D)
Name:
AV45 (R&D)
Active Principle:
Florbetapir
Therapeutic Action:
It is indicated for estimating the density of β-amyloid neuritic plaque in the brain of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease and other causes of cognitive impairment. It is a supplement to other diagnostic evaluations.
RELATED PRODUCTS
-
STANNOUS CHLORIDE
STANNOUS CHLORIDEIt is indicated for: - Performing scintigraphic studies of the blood pool of the heart and great vessels. - Circulatory and placental studies. - Evaluation of gastrointestinal bleeding (especially to locate... -
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness...

